Market capitalization | JPY2.95t |
Enterprise Value | JPY-8.35t |
P/E (TTM) P/E ratio | 15.58 |
EV/Sales (TTM) EV/Sales | -8.26 |
P/S ratio (TTM) P/S ratio | 2.92 |
P/B ratio (TTM) P/B ratio | 1.07 |
Dividend yield | 1.80% |
Last dividend (FY25) | JPY23.00 |
Revenue growth (TTM) Revenue growth | 18.30% |
As a Free StocksGuide user, you can view scores for all 6,883 stocks worldwide.
11 Analysts have issued a Resona forecast:
11 Analysts have issued a Resona forecast:
Sep '24 |
+/-
%
|
||
Revenue | 1,011,383 1,011,383 |
18%
18%
|
|
Gross Profit | - - |
-
|
|
EBITDA | - - |
-
|
EBIT (Operating Income) EBIT | 279,185 279,185 |
21%
21%
|
Net Profit | 190,665 190,665 |
19%
19%
|
In millions JPY.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Resona Holdings, Inc. engages in the management and supervision of its group companies which engages in the provision of banking and financial services. It operates through the following segments: Consumer Banking, Corporate Banking, Market Trading, Kansai Mirai Financial Group, and Others. The Consumer Banking segment provides consulting services regarding consumer loan, asset management and asset succession to individual customers. The Corporate Banking segment offers services such as corporate loan, trust asset management, real estate, corporate pension, and asset succession to corporate customers. The Market Trading segment deals with short-term lending, borrowing, bond purchase and sale, and derivatives trading businesses. The Kansai Mirai Financial Group segment handles the operations of Kansai Mirai Financial Group, Inc. The Others segment includes management of businesses not part of the other segments. The company was founded on December 12, 2001 and is headquartered in Tokyo, Japan.
Head office | Japan |
CEO | Masahiro Minami |
Employees | 19,721 |
Founded | 2001 |
Website | www.resona-gr.co.jp |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.